BMf-BH3 belongs to the Bcl-2 apoptosis mediator family. BH3-only protein, Bmf is a key molecule for histone deacetylase (HDAC) inhibitors mediated enhancing effect on ionizing radiation-induced cell death.
CAT No: R1239
BMf-BH3 is a synthetic peptide derived from the BH3 domain of the Bcl-2 modifying factor (BMf), a pro-apoptotic member of the Bcl-2 protein family. As a mimetic of the native BH3 motif, this peptide is engineered to selectively interact with anti-apoptotic Bcl-2 family proteins, thereby modulating mitochondrial-mediated apoptosis pathways. Its unique sequence composition and structural fidelity make it a valuable tool for dissecting the molecular mechanisms of programmed cell death, with particular relevance to studies of cellular stress responses, cancer biology, and apoptosis regulation. The ability of BMf-BH3 to emulate the functional properties of endogenous BH3 domains positions it as a critical reagent for both fundamental and applied research into cell fate decisions.
Apoptosis pathway investigation: BMf-BH3 is extensively utilized in research aimed at elucidating the molecular underpinnings of apoptosis. By introducing this peptide into cellular systems, investigators can probe the specific interactions between pro-apoptotic and anti-apoptotic Bcl-2 family members. The peptide's capacity to bind anti-apoptotic proteins such as Bcl-2, Bcl-xL, and Mcl-1 enables the study of mitochondrial outer membrane permeabilization (MOMP) and cytochrome c release, providing mechanistic insights into the initiation of the intrinsic cell death cascade. Such studies are crucial for unraveling the complexities of apoptosis regulation in both normal and pathological contexts.
Protein-protein interaction studies: The BMf-BH3 peptide serves as a powerful molecular probe for mapping the binding affinities and specificities of Bcl-2 family proteins. In vitro assays employing this peptide facilitate quantitative and qualitative analyses of protein-protein interactions, enabling researchers to assess the competitive binding dynamics that govern apoptotic signaling. These studies often employ techniques such as fluorescence polarization, surface plasmon resonance, or co-immunoprecipitation, allowing for precise characterization of the molecular determinants that underlie BH3 domain recognition and selectivity.
Cancer research and drug discovery: The pro-apoptotic activity modeled by BMf-BH3 is highly relevant to oncology research, where dysregulation of Bcl-2 family proteins is a hallmark of many malignancies. By leveraging this peptide in cellular and biochemical assays, researchers can evaluate the apoptotic thresholds of cancer cells and screen for small-molecule inhibitors or mimetics that disrupt anti-apoptotic protein function. Such applications are instrumental in the preclinical assessment of candidate compounds targeting the Bcl-2 pathway, supporting the rational design of novel apoptosis-inducing agents.
Peptide-functional studies: The BMf-BH3 sequence is frequently employed in structure-function analyses to dissect the critical residues responsible for pro-apoptotic activity. Through mutagenesis, truncation, or chemical modification of the peptide, investigators can delineate the minimal motifs required for biological function and map the structural features essential for binding specificity. These studies enhance understanding of BH3 domain biology and inform the development of optimized peptide-based probes or inhibitors for further research applications.
Cell-based assay development: The functional properties of BMf-BH3 make it an effective reagent for the design and validation of cell-based assays that monitor apoptotic responses. When introduced into cultured cells, the peptide can induce mitochondrial depolarization and caspase activation, serving as a positive control or reference standard for evaluating the efficacy of test compounds or genetic interventions. Its reproducible activity supports the establishment of robust, high-throughput screening platforms for apoptosis modulators, contributing to both basic research and translational studies in cell death biology.
3. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
5. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More